<DOC>
	<DOCNO>NCT00157846</DOCNO>
	<brief_summary>The goal X-Change HF estimate effect biventricular stimulation patient need antibradycardia ventricular stimulation ( 80 % ) ; eligible exchange old pacemaker implantable cardioverter defibrillator ( ICD ) ; ventricular dysfunction ( left ventricular ejection fraction [ LVEF ] &lt; 35 % ) . All patient eligible participation study upgrade cardiac resynchronization therapy ( CRT ) -device receive either right ventricular biventricular stimulation crossover protocol . The endpoint functional performance measure spiroergometry .</brief_summary>
	<brief_title>X-Change HF - Exchange Existing Pacemaker/ICD Bradycardia Patients Suffering From Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Implanted dualchamber pacemaker ICD system replacement indication Because battery end life Because upgrade pacemaker ICD system predominant sinus rhythm ( paroxysmal atrial fibrillation [ AF ] &lt; 2 hours/day ) predominant ventricular stimulation ( &gt; = 80 % ) NYHA Class IIIII LVEF &lt; = 35 % NYHA Class IV Life expectancy less one year accompany disease Myocardial infarction le 3 month old Cardiac surgery le 3 month Bypass Valve surgery Percutaneous transluminal coronary angioplasty ( PTCA ) Thoracotomy , implant epicardial LV electrode Medical circumstance make participation compliance impossible Patients willing able give write consent study participation Participation another study Patients le 18 year old Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>LVEF &lt; 35 %</keyword>
	<keyword>Bradycardia</keyword>
</DOC>